Literature DB >> 7626573

Clinical comparison of semiconductor diode versus neodymium: YAG non-contact cyclo photocoagulation.

M W Ulbig1, D A McHugh, A I McNaught, A M Hamilton.   

Abstract

AIMS: The advent of diode lasers has allowed their use in transscleral cyclo photocoagulation for refractory glaucoma. A trial was performed to compare the ocular hypotensive and inflammatory effects of cyclo photocoagulation using a continuous wave diode (810 nm) and a free running neodymium:yttrium aluminium garnet (Nd:YAG) laser (1064 nm).
METHODS: Forty patients with refractory glaucoma were randomised to receive either diode or Nd:YAG therapy. The intraocular pressure (IOP) and inflammatory response to treatment were monitored over 3 months.
RESULTS: There was no significant laser related difference in the effect on IOP after one treatment. There was, however, a difference in effect in retreatments with the IOP lowering effect significantly less, but equally sustained in diode retreatment patients. Severe postoperative complications such as hyphaema or fibrinous anterior uveitis only occurred in the Nd:YAG group.
CONCLUSION: The degree and duration of the ocular hypotensive response to cyclo photocoagulation appears to be related to the available power output of the system used, and the extent of tissue damage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626573      PMCID: PMC505168          DOI: 10.1136/bjo.79.6.569

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Transscleral cyclophotocoagulation using a semiconductor diode laser in cadaver eyes.

Authors:  H L Hennis; E Assia; W C Stewart; U F Legler; D J Apple
Journal:  Ophthalmic Surg       Date:  1991-05

2.  A comparison of neodymium: yttrium aluminum garnet and diode laser transscleral cyclophotocoagulation and cyclocryotherapy.

Authors:  E I Assia; H L Hennis; W C Stewart; U F Legler; A N Carlson; D J Apple
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

3.  Optical properties of human sclera, and their consequences for transscleral laser applications.

Authors:  A Vogel; C Dlugos; R Nuffer; R Birngruber
Journal:  Lasers Surg Med       Date:  1991       Impact factor: 4.025

4.  Semiconductor diode laser transscleral cyclophotocoagulation in patients with glaucoma.

Authors:  H L Hennis; W C Stewart
Journal:  Am J Ophthalmol       Date:  1992-01-15       Impact factor: 5.258

5.  [Clinical use and results of trans-scleral Nd-YAG cyclophotocoagulation in therapy-refractory glaucoma].

Authors:  H P Heidenkummer; G Mangouritsas; A Kampik
Journal:  Klin Monbl Augenheilkd       Date:  1991-03       Impact factor: 0.700

6.  Transscleral neodymium-YAG cyclophotocoagulation. A histologic study of human autopsy eyes.

Authors:  C Hampton; M B Shields
Journal:  Arch Ophthalmol       Date:  1988-08

7.  Transscleral cyclophotocoagulation using a neodymium YAG laser.

Authors:  F Fankhauser; E van der Zypen; S Kwasniewska; P Rol; C England
Journal:  Ophthalmic Surg       Date:  1986-02

8.  Contact diode laser cyclo-photocoagulation for refractory glaucoma. A pilot study.

Authors:  M W Ulbig; D McHugh; A McNaught; P Hamilton
Journal:  Ger J Ophthalmol       Date:  1994-08

9.  Evaluation of a protocol for transscleral neodymium: YAG cyclophotocoagulation in one hundred patients.

Authors:  C Hampton; M B Shields; K N Miller; M Blasini
Journal:  Ophthalmology       Date:  1990-07       Impact factor: 12.079

10.  Early tissue response to transscleral neodymium: YAG cyclophotocoagulation.

Authors:  M Blasini; R Simmons; M B Shields
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-06       Impact factor: 4.799

View more
  9 in total

1.  Pathology of cyclodiode laser: a series of nine enucleated eyes.

Authors:  P A McKelvie; M J Walland
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Cyclodestructive procedures for refractory glaucoma.

Authors:  Monica F Chen; Carole H Kim; Anne L Coleman
Journal:  Cochrane Database Syst Rev       Date:  2019-03-10

3.  Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

Authors:  T Schlote; M Derse; M Zierhut
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

4.  Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation in Patients with a History of Keratoplasty.

Authors:  Jun Hui Lee; Vivian Vu; Gabriel Lazcano-Gomez; Katherine Han; Pukkapol Suvannachart; Jennifer Rose-Nussbaumer; Julie Schallhorn; David Hwang; Ying Han
Journal:  J Ophthalmol       Date:  2020-07-09       Impact factor: 1.909

5.  Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma.

Authors:  M E Iliev; S Gerber
Journal:  Br J Ophthalmol       Date:  2007-05-10       Impact factor: 4.638

6.  A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma.

Authors:  C C Murphy; C A M Burnett; P G D Spry; D C Broadway; J P Diamond
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

7.  Controlled Cyclophotocoagulation with diode laser in refractory glaucoma and long term follow up at King Abdulaziz University Hospital, Riyadh.

Authors:  Essam A Osman; Abdulrahman Al-Muammar; Ahmed Mousa; Hani Al-Mezaine; Saleh A Al-Obeidan
Journal:  Saudi J Ophthalmol       Date:  2010-01-07

8.  A retrospective analysis of long-term outcomes following a single episode of transscleral cyclodiode laser treatment in patients with glaucoma.

Authors:  Ivailo Zhekov; Razia Janjua; Humma Shahid; Nicholas Sarkies; Keith R Martin; Andrew J R White
Journal:  BMJ Open       Date:  2013-07-06       Impact factor: 2.692

9.  Current surgical options for the management of pediatric glaucoma.

Authors:  Jose Morales; Sami Al Shahwan; Sami Al Odhayb; Ibrahim Al Jadaan; Deepak P Edward
Journal:  J Ophthalmol       Date:  2013-04-24       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.